Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Earnings
Contineum Therapeutics, Inc. Class A Common Stock is expected to report next earnings on August 4, 2026 (in NaN days), with a consensus EPS estimate of $-0.46. CTNM has beaten EPS estimates in 2 of its last 7 reported quarters (average surprise +3.7% over the last four).
Next earnings
Aug 4, 2026in NaN days
EPS est $-0.46 · Revenue est —
Track record
Beat EPS in 2 of 7 quarters
Avg surprise +3.7% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 5, 2026 | $-0.55 | $-0.39 | +29.1% | — | — |
| Mar 5, 2026 | $-0.39 | $-0.49 | -26.0% | — | — |
| Oct 30, 2025 | $-0.58 | $-0.45 | +22.4% | — | — |
| May 14, 2025 | $-0.56 | $-0.62 | -10.7% | — | — |
| Mar 6, 2025 | $-0.44 | $-0.56 | -27.3% | — | — |
| Aug 13, 2024 | $-0.35 | $-0.39 | -11.4% | — | — |
| May 16, 2024 | $-0.46 | $-3.55 | -671.7% | — | — |
| Dec 30, 2023 | — | $-0.31 | — | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.